Guangzhou Trojan Parmatec Ltd

Guangzhou, China

We are offering flibanserin hcl.Nmae: flibanserin hclmf: c20h22clf3n4omw: 426.86cas147359-76-0character: white powderpurity: 99.0% flibanserin (inn, usan) (developmental code name bimt-17; proposed trade names girosa and addyi) is a drug that is being studied as a non-hormonal treatment for pre-menopausal women with hypoactive sexual desire disorder (hsdd). Development by boehringer ingelheim was halted in october 2010 following a negative evaluation by the u.s. Food and drug administration. The rights to the drug were then transferred to sprout pharmaceuticals, which is continuing the drug development process. On june 4, 2015, the panel to the fda recommended approval of the drug by 186. On august 18 2015, flibanserin (addyi) 100mg has been approved by the fda.

We are offering lorcaserin hydrochloride, our provided lorcaserin hydrochloride is specifically indicated as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in clinically obese adults (bmi of 30 kgm2 or greater) and overweight adults (bmi of 27 kgm2 or greater) with at least one weight-related comorbid condition. specifications:- cas:846589-98-8, mf:c11h14clnhcl, mv: 232.15. clients can avail this lorcaserin hydrochloride at industry leading prices from us.

We are offering flibanserin hydrochloride.Name: flibanserin hclmf: c20h22clf3n4omw: 426.86cas147359-76-0character: white powderpurity: 99.0% flibanserin (inn, usan) (developmental code name bimt-17; proposed trade names girosa and addyi) is a drug that is being studied as a non-hormonal treatment for pre-menopausal women with hypoactive sexual desire disorder (hsdd). Development by boehringer ingelheim was halted in october 2010 following a negative evaluation by the u.s. Food and drug administration. The rights to the drug were then transferred to sprout pharmaceuticals, which is continuing the drug development process. On june 4, 2015, the panel to the fda recommended approval of the drug by 186. On august 18 2015, flibanserin (addyi) 100mg has been approved by the fda.